IDEXX Laboratories, Inc. Stock
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
499.3 USD | +2.06% | +4.82% | -10.04% |
04-01 | Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board | MT |
04-01 | Elanco appoints two directors after settling with activist Ancora | RE |
Sales 2024 * | 3.99B 5.45B | Sales 2025 * | 4.39B 6B | Capitalization | 41.49B 56.71B |
---|---|---|---|---|---|
Net income 2024 * | 928M 1.27B | Net income 2025 * | 1.04B 1.43B | EV / Sales 2024 * | 10.5 x |
Net Debt 2024 * | 461M 629M | Net Debt 2025 * | 264M 360M | EV / Sales 2025 * | 9.51 x |
P/E ratio 2024 * |
44.9
x | P/E ratio 2025 * |
39.5
x | Employees | 11,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.52% |
Latest transcript on IDEXX Laboratories, Inc.
1 day | +2.06% | ||
1 week | +4.82% | ||
Current month | -7.53% | ||
1 month | -5.90% | ||
3 months | -4.89% | ||
6 months | +25.63% | ||
Current year | -10.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 12-07-31 | |
Brian McKeon
DFI | Director of Finance/CFO | 61 | 03-06-30 |
John Hart
COO | Chief Operating Officer | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 14-03-10 |
M. Szostak
BRD | Director/Board Member | 73 | 12-07-15 |
Chairman | 61 | 16-10-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.32% | 1 M€ | -.--% | ||
1.59% | 18 M€ | +3.79% | - | |
1.14% | 2 M€ | -1.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 499.3 | +2.06% | 529,834 |
24-04-25 | 489.2 | -1.02% | 358,641 |
24-04-24 | 494.3 | +0.09% | 493,145 |
24-04-23 | 493.8 | +2.97% | 558,418 |
24-04-22 | 479.6 | +0.68% | 419,598 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
- Stock Market
- Equities
- IDXX Stock